Shares of Spherix Inc. soared 21% in active morning trading Friday, after the biotechnology company said it executed an exclusive option agreement with the University of Maryland, Baltimore for the technology in the patent for "Methods of Treating Coronavirus Infection." Trading volume swelled to 2.2 million shares, already more than the full-day average of 1.2 million shares. The company said the invention was made with support awarded by the National Institutes of Health, which has certain rights in the invention. Under terms of the option, Spherix said it has until the end of May to execute a license agreement for commercial development. The stock has lost 23% over the past three months, while the iShares Nasdaq Biotechnology ETF has slipped 2.5% and the S&P 500 has shed 6.9%.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Mainland China reports 139 new coronavirus casesMainland China had 139 new confirmed cases of coronavirus infections on Wednesda...
Les mer »
California declares emergency over coronavirus as death toll rises in U.S.California Governor Gavin Newsom declared a statewide emergency in response to the coronavirus
Les mer »
COVID-19 epidemic can be pushed back with concerted approach: WHOThe epidemic of COVID-19 coronavirus infection spreading around the world can be contained and controlled, the WHO said, but only with a concerted response by all governments
Les mer »
Cases in China slow as global infections approach 100,000Cases of coronavirus in China slow as global infections approach 100,000.
Les mer »
Coronavirus infections jump to 82 in the Netherlands: RIVMThe number of patients infected with the coronavirus in the Netherlands has more...
Les mer »